Development of prognostic factors and survival in cutaneous melanoma over 25 years
Open Access
- 20 January 2005
- Vol. 103 (3) , 616-624
- https://doi.org/10.1002/cncr.20816
Abstract
BACKGROUND Recent studies revealed that incidence rates of cutaneous melanoma (CM) were leveling off predominantly among younger people and patterns suggested birth-cohort effects. The current study analyzed the development of prognostic factors and survival in incident CM over 25 years. METHODS All 45,483 patients with incident CM diagnosed between 1976 and 2000 recorded by the German Central Malignant Melanoma Registry were considered. Linear and logistic regression analyses were used to judge time trends. Trends of survival rates were tested with the multivariate Cox model. RESULTS Median tumor thickness decreased from 1.81 mm in 1976 to 0.53 mm in 2000 (P < 0.0001). The percentages of in situ and level II CM increased, respectively (P < 0.0001). The percentage of ulcerated CM decreased (P < 0.0001). The percentage of superficial spreading melanoma increased, whereas the percentage of nodular melanoma decreased (P < 0.0001). These time trends were all significant in the strata of gender, however, male patients presented in general with more advanced disease. Between 1976 and 2000, the average patient got older (P < 0.0001). The percentage of patients diagnosed with the primary tumor alone increased (P < 0.0001). Across the 25 years of observation, adjusted survival rates did not increase for females (P = 0.1561) but they increased for males (P < 0.0001). CONCLUSIONS The data demonstrated a strong trend towards prognostically more favorable CM most likely due to earlier diagnosis. Men and older people should be the focus of health promotion activities as they presented with more advanced disease. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 35 references indexed in Scilit:
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in ScandinaviaInternational Journal of Cancer, 2003
- Survival probabilities and hazard functions of malignant melanoma in Germany 1972–1996, an analysis of 10 433 patients. Evolution of gender differences and malignancyEuropean Journal Of Cancer, 2002
- Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993International Journal of Epidemiology, 2000
- Public awareness of malignant melanoma risk factors in Germany.Journal of Epidemiology and Community Health, 1997
- Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94BMJ, 1997
- Increasing Incidence of Cutaneous Melanoma in Queensland, AustraliaJNCI Journal of the National Cancer Institute, 1992
- Cutaneous malignant melanoma, Scotland, 1979-89The Lancet, 1992